Hung-sen Lai

This inventor holds 37 USPTO granted patents and 25 published patent applications and 8 EPO patents, primarily in Cancer Therapeutics. Top assignees: Tufts University, Bach Biosciences, LLC, Arisaph Pharmaceuticals, Inc.. Active years: 2007-2025.

USPTO Granted Patents = 37 (Patent Applications = 25)

% Patents Active = 64.9

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 137(Granted Patents)

Location History:

Winchester, MA (US) (2007)
Andover, MA (US) (2011 - 2024)

Company Filing History:

Bach Biosciences, LLC

patents

3 out of 3

Arisaph Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

FAP Inhibitors

Combination Therapies

Proteasome Inhibitors

Immuno-DASH Inhibitors

PGE2 Antagonists

Cancer Treatment

Radiopharmaceuticals

Niacin Mimetics

Soft Protease Inhibitors

Fibroblast Activation Protein

Peptide Therapeutics

Anticancer Agents

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12478609 - Combination therapies using immuno-DASH inhibitors and PGE2 antagonists (2025-11-25),

2. 12214047 - FAP-activated proteasome inhibitors for treating solid tumors (2025-02-04),

3. 12121505 - Fap-activated therapeutic agents, and uses related thereto (2024-10-22),

4. 12053450 - FAP-activated therapeutic agents, and uses related thereto (2024-08-06),

5. 12023316 - FAP-activated therapeutic agents, and uses related thereto (2024-07-02),

6. 11957657 - Combination therapies using immuno-dash inhibitors and PGE2 antagonists (2024-04-16),

7. 11925655 - FAP-activated therapeutic agents, and uses related thereto (2024-03-12),

8. 11707539 - FAP-targeted radiopharmaceuticals and imaging agents, and uses related thereto (2023-07-25),

9. 11583516 - Dash inhibitors, and uses related thereto (2023-02-21),

10. 11559537 - Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists (2023-01-24),

11. 11266669 - FAP-activated therapeutic agents, and uses related thereto (2022-03-08),

12. 11096924 - Combination therapies using immuno-dash inhibitors and PGE2 antagonists (2021-08-24),

13. 11065339 - FAP-activated proteasome inhibitors for treating solid tumors (2021-07-20),

14. 11033525 - Fap-activated therapeutic agents, and uses related thereto (2021-06-15),

15. 10709722 - FAP-activated therapeutic agents, and uses related thereto (2020-07-14),

Title: Inventor Hung-sen Lai: Revolutionizing Technology in Andover

Introduction: Hung-sen Lai is a pioneering inventor based in Andover, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Hung-sen Lai holds several patents in various technological domains, including advancements in artificial intelligence, renewable energy, and telecommunications.

Career Highlights: With a career spanning over two decades, Hung-sen Lai has worked with prestigious tech companies, leading research institutions, and universities to develop cutting-edge solutions that have reshaped industries.

Collaborations: Throughout his career, Hung-sen Lai has collaborated with top engineers, scientists, and researchers globally, fostering a culture of innovation and excellence in every project he undertakes.

Conclusion: Hung-sen Lai's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true visionary in the world of inventions.